⏳ Fetching live dividend data...
Home › Calculator › TRYPF Dividend Calculator 2026
Tryp Therapeutics Inc. · OTC
Price: $0.06 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TRYPF → $42982373376373.03M in 10 years · $3,483,965,030,669,279,700.00/month
Tryp Therapeutics Inc. is a biopharmaceutical company dedicated to identifying and advancing novel therapeutic compounds for medical conditions characterized by significant unmet needs. Its flagship development initiative, known as PFN, focuses on addressing neuropsychiatric disorders by utilizing precisely formulated synthetic psilocybin. Within the PFN framework, specific drug candidates TRP-8802 and TRP-8803 are being developed to potentially treat a range of complex conditions, including fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. To support its research and clinical endeavors, the company collaborates with Calvert Labs for the conceptualization and execution of exploratory studies related to its psilocybin-based neuropsychiatric program. Additionally, a partnership with Fluence provides essential guidance and instruction for the psychotherapeutic components of Tryp's clinical trials. Established in 2019, the organization initially operated as Artos Pharma Corp. before rebranding as Tryp Therapeutics Inc. in June 2020. Its operations are headquartered in Kelowna, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TRYPF position with:
Real after-tax yield depends on where you live and how you hold TRYPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3558.72% | 3555.92% | $355,872 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3024.91% | 3022.11% | $302,491 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2846.98% | 2844.18% | $284,698 / yr |
| 🇬🇧 UK ISA | 0% | 3558.72% | 3555.92% | $355,872 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3247.33% | 3244.53% | $324,733 / yr |
| 🇨🇦 TFSA | 0% | 3558.72% | 3555.92% | $355,872 / yr |
| 🇨🇦 CA Taxable | 25% | 2669.04% | 2666.24% | $266,904 / yr |
| 🇦🇺 Super (pension) | 15% | 3024.91% | 3022.11% | $302,491 / yr |
| 🇦🇺 AU Taxable | 30% | 2491.10% | 2488.30% | $249,110 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2620.11% | 2617.31% | $262,011 / yr |
| 🇫🇷 FR Taxable | 30% | 2491.10% | 2488.30% | $249,110 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
TRYPF pays quarterly — 4 times per year. Next ex-div: TBD.
How TRYPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TRYPF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TRYPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Tryp Therapeutics Inc. (TRYPF) is currently trading at $0.06, 93% below its 52-week high. The current dividend yield is 3558.72% based on an annual payout of $2.00 per share.
Tryp Therapeutics Inc. (TRYPF) is a healthcare stock currently trading at $0.06 with a dividend yield of 3558.72%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever